1. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol;Vogelpoel;J Pharm Sci,2004
2. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms;World Health Organization,2006
3. Guideline on the investigation of bioequivalence. Accessed August 03,2010, at:;European Medicines Agency, Committee for Medicinal Products for Human Use,2010
4. Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutical classification system. Accessed August 03, 2010, at:;U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,2000
5. International Pharmaceutical Federation (FIP). Biowaiver monographs. Special interest group on biopharmaceutics classification system (BCS). Accessed January 25, 2010, at:http://www.fip.org/www2/sciences/index.php?page=pharmacy_sciences&pharmacy_sciences=ps_sig_bcs